Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at SGD 268.5B, ahead of Johnson & Johnson (SGD 256.9B) and Sanofi (SGD 181.5B). Figures as of 18 Nov 2026, 15:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSGD 268.5B
- Median
- SGD 4.5B
- Combined market value
- SGD 6.55T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SGD 268.5B | SGD 206.9B | SGD 36.30 | 1.14% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SGD 256.9B | SGD 853.8B | SGD 354.69 | 1.32% down | 38% up | ||
| 3 | SanofiSNY · Health Care | SGD 181.5B | SGD 146.5B | SGD 60.99 | 0.50% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SGD 176.5B | SGD 444.2B | SGD 180.19 | 2.55% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | SGD 172.8B | SGD 655.2B | SGD 370.68 | 1.85% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | SGD 147.1B | SGD 357.7B | SGD 230.66 | 1.88% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | SGD 145.1B | SGD 1.6T | SGD 1,796.88 | 1.58% down | 35% up | ||
| 8 | NovartisNVS · Health Care | SGD 143.1B | SGD 380.9B | SGD 201.69 | 1.73% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | SGD 125.3B | SGD 88.1B | SGD 27.57 | 1.22% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SGD 116.1B | SGD 157.7B | SGD 77.16 | 2.48% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SGD 111.8B | SGD 232.7B | SGD 134.36 | 0.51% down | 17% down | ||
| 12 | GSKGSK · Health Care | SGD 104.6B | SGD 126.3B | SGD 62.99 | 0.81% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SGD 103.9B | SGD 224.5B | SGD 50.94 | 2.96% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 52.6B | SGD 63.6B | SGD 54.50 | 0.84% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SGD 52.3B | SGD 127.4B | SGD 1,231.60 | 0.30% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | SGD 48B | SGD 30.4B | SGD 26.55 | 0.66% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SGD 33.1B | SGD 174.3B | SGD 687.56 | 0.21% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | SGD 28.2B | SGD 7.5B | SGD 10.98 | 1.39% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SGD 25.3B | SGD 50.7B | SGD 88.14 | 0.50% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | SGD 19.9B | SGD 43.8B | SGD 107.91 | 0.23% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | SGD 17.2B | SGD 16.9B | SGD 33.88 | 1.62% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | SGD 16.6B | SGD 40.8B | SGD 66.11 | 1.35% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 15B | SGD 20.1B | SGD 312.97 | 0.81% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | SGD 10.6B | SGD 59.4B | SGD 520.41 | 2.36% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | SGD 10.2B | SGD 31.3B | SGD 735.18 | 2.41% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SGD 9.8B | SGD 14.9B | SGD 76.98 | 2.02% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 8B | SGD 16.1B | SGD 19.28 | 1.05% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | SGD 7.4B | SGD 36.1B | SGD 49.80 | 0.25% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SGD 6.4B | SGD 26.4B | SGD 197.37 | 2.21% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.6B | SGD 27.66 | 1.56% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SGD 4.5B | SGD 5.8B | SGD 34.90 | 0.37% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | SGD 3.7B | SGD 6.5B | SGD 77.69 | 0.20% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | SGD 3.2B | SGD 10B | SGD 59.69 | 1.83% up | 58% up | ||
| 34 | InsmedINSM · Health Care | SGD 2.9B | SGD 33.7B | SGD 153.77 | 2.16% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | SGD 2.2B | SGD 4B | SGD 20.70 | 0.37% down | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | SGD 2B | SGD 7.6B | SGD 380.11 | 0.31% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | SGD 1.9B | SGD 22.8B | SGD 348.27 | 0.43% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | SGD 1.8B | SGD 9.3B | SGD 66.61 | 0.01% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.8B | SGD 7.8B | SGD 55.49 | 0.08% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.6B | SGD 12.4B | SGD 533.27 | 2.02% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | SGD 1.4B | SGD 12.3B | SGD 81.59 | 0.88% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.2B | SGD 11B | SGD 393.50 | 0.01% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | SGD 1.2B | SGD 6.3B | SGD 36.42 | 1.38% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | SGD 1.2B | SGD 19.4B | SGD 99.61 | 0.56% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | SGD 1.1B | SGD 7.7B | SGD 117.52 | 0.90% down | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | SGD 1.1B | SGD 9.5B | SGD 86.93 | 3.81% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | SGD 1B | SGD 8.3B | SGD 204.57 | 0.57% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | SGD 1B | SGD 11.5B | SGD 121.51 | 0.43% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 984.9M | SGD 9.7B | SGD 123.17 | 0.41% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | SGD 968.8M | SGD 10.9B | SGD 13.59 | 1.22% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | SGD 889.7M | SGD 9B | SGD 170.77 | 2.60% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | SGD 861.8M | SGD 10.5B | SGD 160.56 | 0.14% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | SGD 836.2M | SGD 9.4B | SGD 107.76 | 1.77% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | SGD 780.5M | SGD 6.2B | SGD 64.36 | 2.35% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | SGD 712.7M | SGD 5.8B | SGD 52.52 | 3.13% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | SGD 684.7M | SGD 6.3B | SGD 111.07 | 0.99% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | SGD 630.2M | SGD 8.4B | SGD 124.34 | 0.09% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 619.3M | SGD 10.4B | SGD 150.29 | 0.07% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | SGD 567.6M | SGD 5B | SGD 36.76 | 3.00% down | 169% up | ||
| 60 | ErascaERAS · Health Care | SGD 510.9M | SGD 5.9B | SGD 16.95 | 5.40% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 196.8M | SGD 6.7B | SGD 159.22 | 1.74% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2897 SGD).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (SGD 268.5B), Johnson & Johnson (SGD 256.9B) and Sanofi (SGD 181.5B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 15:42 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of SGD 6.55T as of 18 Nov 2026, 15:42 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.